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IN'l'HOP!JC1'ION 
filth the recent development of a rapid and reliable 
method for the determination of the enzyme, Glutamic Oxalacetic 
'l'ransaJ'l11.na.se (GO-I}.'), oonsiderable interest has been aroused In 
the olinical implications of increased levels of this enzyme in 
human and animal sera during oertain pathological states. GO-T 
serves as a catalyst for the reversible reaotion oi" a.lpha-keto-
glutarate and I-aspartate to produce oxa1acetate and I-glutamate. 
It is widely dIstributed in anImal and human tissues but its 
greatest activity has been found in homogenates ot heart musole, 
skeletal muscle, braln, liver, kidney, testis, lung and spleen, 
in decreaslng order (15) (14). The enzyme has also been found in 
all sera that have been tested (27) (63) and 1n normal human 
serum the range Is from 8 to 40 unIts with a mean of 22.1 unIts 
and a standard deviation or :!:. 6.8 units (33) (45). 'rhe definition 
of a unit is g'lven on page 4 of the thesis. Seru.'1.l Glutamic Oxal-
acetic Transam1nase (SOO-'1') hms been found to be species specific 
and In rats the normal range is from 170 to 350 un1ts (45). 
while 1n the mouse it v8.ries from 50 to 125 units (21). In the 
human, normal urine oontains less than 1 un1t of SOO-T (58). 
Methods tor the Determination c,f Transam1pas6 ActivltI 
Although it had boen known for more than ten years 
2 
that the SGO-T level varied widely in diseases involving tissues 
which oontain high levels of the enzyme, little clinioal work 
h.ad been done to correlate these facts until recent years since 
all of the methods available for the dete~nination of SGO-T 
were slow, complicated and unreliable. 'l'he earlier methods for 
determining the transamination reaotions may be divided into two 
main types: Those whioh utilize either specifio chemical or 
enzymatic decarboxylation of one of the products /lnd subsequent 
manometr1c measurement of the carbon dioxide evolved and those 
utilizing the high ultraviolet absorption of oxalacetate at wave 
length 280 millimicrons to follow the reaction as oxalacetate is 
produced or consumod. The high bicarbonate content or blood to-
gether with the low transaminase activity makes a method depend-
ing on carbon dioxide evolution difficult to apply to serum. Low 
transaminase and high protein oontent together with the known 
instability of oxalacetate makes the speotrophotometrio assay 
difficult to apply to serum also. Ultimately a ohromatographic 
method was devised for the determination ot SGO-T which, though 
slow I was l' }liable (27). 'I'his method was the forerunner of the 
currently popular spectrophotometrio method. 
In the chromatographic method (1) (6), the substrates, 
l-aspartate s.nd alpha-ketoglutarate J are inoubated in phosphate 
burter (48) with a source of GO-'l' and the rate of production of 
l-glutamate 1s taken as the measure of transaminase activity. 
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After the incubation, the proteins are precipitated and removed 
from the supernatant. Aliquots of the supernatant are then chro-
matographed by the desoending method for eir:)lteen hours, using 
phenol saturated with water as the solvent and water saturated 
with phenol to saturate the atmosphere ot the tank. 'l'he position 
of the glutamate can be located by spraying the paper with nin-
hydrin. The areas of paper correapoading to glutamate are out 
out and the amino acid eluted tram the paper, after which ita 
concent~ation is quantitatively determined by a colorimetric 
procedure using ninhydrin as the reagent (6l).This procedure has 
the disadvantage of being time-oonsuming, taking as much as two 
days to complete an analysis. 
A spectrophotometric method has now been devised (26) 
(4) for the determination ot SGO-T in which the transamination 
reactlon i8 coupled to the reductlon of oxalacetate to malate by. 
reduced dlphosphopyridlne nucleotide (DPNH) in the presence of 
excess lnnlic dehydrogenase (59). 'l'he oxidation of DPNH, and 
therefore the transamination reaction, 1s followed by Measuring 
the decrease in light absorption at wave length 340 millimicrons, 
at which the reduced pyridine nuoleotldes have an absorption 
peak (46). 
In this procedure, the serum sample 1s incubated in a 
pH rl.4 phosphate burfer solution I'll th I-aspartate, reduced Co-
enzyme I and pur1fied mallc dehydrogenase. The blank contains all 
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of the 11sted reactants except the DPNH. Atter Ii suitable inou-
bation period, alpha-ketoglutarate is added to the incubated sol-
ution. The optical densIty at wave length 340 millimiorons is 
tollowed and the rate of decrease ot optical density taken as a 
measure of the transaminase activity ot the serum. The activity 
1s expressed as units per milliliter of serum per minute. One 
unit equals a. decrease in optical density of 0.001 units per 
milliliter per minute at 25°C. (26). 
Serum glutamic oxnlaoetic transaminase is most easily 
and acourately measured by the spectrophotometric procedure but 
the techn1cs desoribed require enzymatio reaeents and speoial 
equipment that are not generally available in the average clini-
cal laboratory of a hospital or In a physician's of rice. A simple 
colorimetrio procedure for the assay of GO-T 1n animal tissues 
was desor1bed by Tonhazy and eo-workers (60) which was based on a 
modificatIon of the Frledemann-Hnugen method (20) for the deter-
mination of keto acids in blood and urine. 'l'b1s technic for 
assaying the activity of SOO-T is based on the transamination of 
l-aspartate and alpha-ketogluta~ate to give oxalaoetate and 1-
glutamate. The oxnlaoetate formed is oonverted to pyruvate by 
aniline citrate. The pyruvate then reacts with dinitrophenyl-
hydrazine to form pyruvate-dlnitropheny1hydrazone. and thIs 1s 
then extracted with toluene. V;hen the toluene solution of pyru-
vate-din1trophenylhydrazone is treated with strong alkali, a 
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eolored compound forms, and this may be measured in a colori-
meter at 490 millimicrons. The intensity of the color is pro-
portional to the amount at' p'yruvate which in turn reflects the 
level of SGO-T activity (9) (62). One unit of SGO-T is defined 
as the amount of actIvity in 1.0 millIliter ot serum that results 
in the formation of ohromogenic material equivalent to one mioro-
gram of pyruvate under conditions of the test (20 minutes at 26°0. 
One unit colorimetrically is roughly equivalent to approximately 
one unit ot' SGO .... T when measured spectrophotom.etricall,. (9). 'I'he 
spectrophotometric technic is the most aocurate and rapid pro-
cedure yet devised t'or the determination of SGO-T actiVity, how-
ever (35) • 
.No change in transaminase activity with time has been 
noted in serum samples stored at room temperature for tour days 
(27) (34) (57) or tor periods of from one hour to two weeks in 
the refrigerator at O-SoC. (27) (33). The transaminase aotivity 
Q.t 370 0. is approximately double that at 25°C. (13). Its acti vi ty 
was not ohanged by freezing or lyophIlIzatIon ot the serum (27). 
No ohange in actIvity was noted In serum subjeoted to saoe. ~or 
25 mlnutes (27). ~e~a heated to 100°C. for 10 minutes were found 
to have Q deorease in aotivity to 10 per oent of the original 
transaminase aotivity. The oonoentration of GO-T 18 the same in 
nerum and plasma but it is as muah as ten times greater In 
hemolyzed samples (27) (33). 
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Relation of SGO-T Levels to Mlocardial .t'tec.ro~ 
Clinical and laboratory st\ldles performed on human 
subjeots have shown that the serum level of GO-'J' rises signifi-
cantly .following acute myooardial infarction (34). However, in 
order to determine the relationsh1p, if any, between Rerltm trans-
aminase levels and the amount of infarcted musole in clinioal 
oases, oareful pathological studies will have to be made on 
autopsy material over a span of mAny years. Therefore attempts 
to determine this relationship in experimental animals have been 
made (2). 
By utilizing the method of Agrees (3), graded experi-
~ental infarction was produced in nembutal anesthetized dogs by 
inJeoting plastic miorospheres into the ooronary ostia. Serial 
blood samples were taken for SGO-T determination and at autopsy 
serial sections ot the heart were made at approximately 1 cm. 
intervals through the left ventricles and septum. The amount of 
infarction was estimated in terms of per cent or total myocardium 
after gross study of the epicardial and endocardial surfaces and 
of the serial sections (2). In all caaes the SGO-T levels rose 
sharply atter myocardial infarction. with rises as great as 20 to 
30 times that o!'the oontrol leyels. The peak transaminase level 
occur» between 9 and 23 hours post injury with a decline atter 
this point. It was also found that a relatively linear correlation 
existed between the peak SGO-T levels and the amount of myocardial 
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Ini'arction as esti!;1atact nt antops~! nnd also that in.fa!'otlon of 
as little ns 10 per cent, and possibly less, of the totnl myo-
c(lI'dium. 1s assooiated '111 th signIficant risen in SGO-'I' 11'3'17e15 (2). 
01n08 this procedure subJeoted the dogs to prolonged 
anesthesi~, and possibly secondary 11ver 1amage, the method 
developed by LeRoy and associates (36) for inducing myooardial 
Int'aretion experimentally was usod in order to exolude SGO-T 
elovation due to injury to hepatic, renal or other transaminase 
rich sources. In this procedure, a left lateral chest inci~ion 
was made, tho fourth rib resected, and nooses of braided sIlk 
loosely placed aro\Uld chosen branohes of coronary arteries. Tho 
ends of the ties were then broue~t out through stab w~xnds 1n 
the ohest at riGht angles to the artory and buried. suboutaneously 
and the dogs were f:l.llowed to recover fl~O!l the oporation. 'l'h~l 
ndvani;aCo ot this method 1s that the M"."ocar(lial lnrnrotlon can 
bo 'prOChlC$d rtt any tittle subseq".lent to tho operation when the 
SG(,-Ir eleVAtion resulting trOt'l injury to skeletal muscle during 
th~ operation has rl"lturned to normal limits. In this 1,''fa:; t tho 
a.ltl~rlltl()n of SaO-T oon~ontra.tlon due to surr,ory is separated 
f,..om that duo to coronary ligation. At the jeslred time, the 
appJ'oprlate ties 'I,vera dra'U'/n tight. occludIng tho ooronary Rrt-
~rlas, anri ser1al venous hloorl smrmles nnd eleotrooardlop,r-a.ms 
were ohtitined. AgHln thf)re was ob8er~/ed an 1nOr99,Se in snO-T 
aotivity within six hours follOWing ligation and both the degree 
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~lnd duration of enzyme abnormality ap-pearen to be proportionAl 
to the size of the infarct as deterrnined at autopsy. It was also 
fotmd that the OO-T uctl'Tlty in infarcted ~j.uscle ls only 2-10 
per cent of that of nor!:'lal heart muscle (35) and ~h9.t the aO-T 
a.ct1 vi ty in 1n£a.rctGd mu.sala dim.1nish"s proP01~tionntel:r t,:> tha 
n.:.:;e of the Inf'urct (51). ':'hi::; atron?;l:r SUE~gests that the :nechan-
1sm. of elavation of SUO-'}' activity is simply one of release of 
the enzyme into the blood str98Jn following death or increase in 
oellular membrane permeability. 
It was also found that myocardia.1 ischemia of' 45 min-
utes duration did not result in increased SGO-IJ' activity. 'l'hls 
1s analoeous to the usual absenoe of inoreased levels followin6 
angina pector1s and coronary insuff1c1enoy 1n :nan assooiated 
\v1 th revers1ble S-'1' and T-wRve ehnnses on the EKf1. 
SOO-'1' has also been found to be elevated when myocard-
lel necrosis was produced tn rabbits by the intravenous injectIon 
of papain (51) (55). Although it shows 3n u.nusual specificity for 
c3rdlR.c rrru.3cle, the p08s1'o11 tty of the effect of !)apa,ln u.pon 
other- tr'lnsa"!1inase rich tissues cannot be ex.cluded. 
It has b·.3en shown that &. filter:lble Virus, Virus III. 
wh.f'm Introduc·:~d into tho ani::1.'1.1 body by the peripheral route 
001;.1:1 sp~clrica.l1y i::-d'ect the he,'l.rt ftnd pro·inc') anatO'!'1'iioal les1on! 
and f'tmctlonnl derlllnr6lnelnt (53) (54). It was frn.md upon olosely 
following the SC'J-T in animals s'.lbjected to intratastlcular it1-
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jeotion ot Vl~. III that every animal with a demonstrable myo-
oarditi. with associated muscle necroala bad a diagnostioally 
significant ris. in SOO-T. Perioardial and endocardial l •• lona, 
de.pIte their aeverity, produoed no change in the SGO-T levela. 
indicating that the elevation ot transamina.e 18 the result ot 
mu.cle injury rather than the viral Inflammatory reactIon (54). 
The re.ult. ot experiment. by NJdiok and a880clate. 
(49) a180 ahow tbat tbe SGO-T aotivity waa within normal It.1ta 
1n experI.ental perioax-ditl. Induced with _gneslum 81l1cat. un-
le.a Bubepicard1al necrosis was found at autopsy and that the 
SGO-T activity remained w1thin normal l1mita 1n 9 of 11 patient. 
wlth aoute pericardit1s of v~iou. etiologie •• In the two re-
mai.ning patient. brier and 1nsignifioant rl.e. (maximum of 56 
un1t.) ocoured ('9). 
In 64 patient. who were stud1ed while in vax-lous 
.tag •• ot rheumatic rever, normal values were round in all oa ••• 
1n wbioh there waa no clinical evidenoe ot aotlve cardiao in-
volve.ent (50). Although tre~uent17 high, the 1 ••• le ot 500·'1' 
.ere not oons1stently elevate4 in patlents wlth aoti •• oarditis 
and did not tollow the c11nlcal cours. ot the dise.s. clo •• 1y. 
'!'he SGO-T test has proved to have great value in the 
diagnosis and prognosia of myocardial Infarotion. ,any d1fterent 
worker. have reported independently on the .tteots ot myocardial 
neorosi. on SGO-T l.vela. LaDu. and a.soolates (33) report elev-
10 
attons ot SGO-T of trom 70 to 600 units within 12 hours· to six 
days post injury 1n 75 patlants studIed. Denny and hls group (17) 
found only three talae negatiye results when the te.t was per-
formed on 95 pat1ents with myocardial intarction. Steinberg (58) 
notes elevated 1eve18 1n over 90 per cent of myocard1al necrosls 
studied. 
Determinations ot SGO-T .ere aade by Kattus and co-
workers (SS) on 111 patients in whIch the d1agnosis of myooard-
lal tntaNtton oould be established on clinical evidence and 
electrocardiograms. All of the •• patient. had elevationa ot SOO-T, 
provide. the .erial level. were obtained during the tirst three 
to six day. follOWing on •• t ot pain. The value. rise rapldl, to 
a peak that 18 usually reached between 24 and 48 hours atter the 
onset of pain. There 1s then a gradual tall over the succeeding 
3 or , day. to normal le.ela. The higher the enay.aatio actIvity, 
the longer the elevations perslat (33). or 37 fatal ca •• a ot myo-
cardlal Intarctlon .~ud1ed by Kattus, 11 were uncomplicated by 
other factor •• All but one or the.e had peak levels of SaO-! 
higher than 350 unit. wlth a range of 357 to 6,567 units. Levels 
ot saO-T oYer 350 units •• em to c~'1 a grave prognosis. Chinaley 
(lS) repvta that of 117 dlagnos.d lnta:rctions, only one ca.e 
tailed to develop a high value when speCimens were taken at proper 
Intenala. ae alao obtained evidence which suggests that the 
appearance ot v.r7 high SGO-T levels may be a poor prognostic 
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sIgn. CbInaky alIa found normal or borderlIne levels (41 to 51 
unital tor ea.e. with the angInal syndrome, acute pulmonary 
edema 1n whom aoute myocardial In1'arotlon was not the precIpitat-
ing caua., ol~onic congestive heart failure due to arteriolcler-
otio cardiac disea ••• and perioarditis •. 
Goldner (23) and literrl1 (41) repo:rt high levels in 
10 and 9 casea, respect1vely, 1n whom the diagnosis myocardIal 
intarotion was definitely establIshed by 011n10al testa or autopsy 
In most CA.es the levela begin to r1a. 6 to 12 hours after ooset, 
reaoh the peak in 24 to 36 hours and deollne to normal by the 
fIfth or slxth day. (29). 
At the ~e.ent time, when oonfronted with the probleDl 
or cheat pain that 18 oonsldered to be oardiac in origin, the 
physio1an regards the eleotrocardIogram aa the tlnal test in 
deo1ding 11' acute myocard1al in.faretion haa ocourred. However, 
early EKG'a may not show evidenoe of recent myocard1al injury o.r 
alae a prevlou8 myooardial Infarct may leave residual electro-
cardlor,raphle Boara that will neutralize wUUlges charaoterIst1c 
of injury ourrent. Another well-establIshed dlffioulty in the 
eleotrocardiograph1c interpretation of recent myocardial Infarot-
10n 18 1ta dIagnosis 1n the presence ot left bundle-branoh block 
(LEBa). Normally, the Interventricular septum Is stimulated from 
lett to r1ght, but In the pre.ence ot LBDB the rlght alde ot the 
septum 18 aotivated f1rst and characteristic injury current 18 
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loat whore IJ.H.m oocurs w1 th recent myooardial Infarotion (32). 
Kraus. bas u.ed the SGO-T method to clarIfy the diagnosis of 
recent myocardial infarotIon In the presence of left bundle-
branch block. 
HomoGenized hea,rt muscle of dogs oontains approximately 
350,000 unIts of CfO-T per gram of homogenIzed tissue (33). It 
all of the enz,me present were released into the oirculation ot 
a 30 kilogram dog, the level in 1 milliliter of serum would be 
approxImately 400 unIts. That thla Is the mechanism by wh1ch 
SGO-T Is elevated following myocardIal infarotion 1s suggested 
by the fact that sampl •• of intarcted muscle (cardiac) may con-
tain as Uttle as 4.000 units per grUht F'urther evidence that 
the enzyme 18 released trom damaged cells is provIde4 by the tact 
that SGO-T ris •• precipItously and In proportion to tbe time elap-
sed atter death ot the mammal studied (33). It 1. of note that 
sample. trom the Jugular vein remain conaiatently low around 40 
units post death wbile sample. drawn trom the 8uperior vena cava 
at the same time may contain as muoh a8 280,000 unIta, the right 
ventricle 160,000 unIts and the thoracio pool 100,000 unit •• 
Since the enayme 18 hIgh 1n brain tissue. a blood brain barrier 
preventing the escape of ::WO-1' trom brain tissue into the cir-
oulation }las been suggested (33). 
The other transamination enzyme of ourrent clinical 
interest, SeI"Wa Glutamio PyruvIc Transaminase (SGP-T) J has not 
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been found to be particularly valuable 1n the diagnoais ot myo-
cardial d1s •• s.s. The level ot SGP.T 1s altered only 1t there la 
extenaive necroaia ot the myocardium. Thus, there 1s usually an 
increaae in SGP-T levels only when the peak level ot saO-T 1s 
more than 100-150 units. Thi. 18 probably accounted tor, 1n part, 
by the tact that the GP-T aotlvity is low 1n heart muscle as 
compared to the high act1vity of GO-T 1n cardiac ti •• U8 (6a) (61). 
The height and duration ot elevated SGO-T activity i. 
thus .een to be roughly proportional to the extent ot myocardial 
necroals. Thi. determination then, haa partioular aignl.ficance 
in decid1ng whether acute heart musele cell damage haa occurred 
when chea' pain, sugge.tive ot acute 810cardial infarction, 
appears and 1 •••• 001ated with equivooal electrocardiographic 
ohange. and other indefinite laboratory finding •• Under the.e 
c1roumatano •• , it the analysi. is done with proper preoaution., 
many pat1ents who have a normal saO-if le.el may be apared .... k. 
of iova1141 .. or unnece.aary anticoagulant therapy_ Converaely, 
1n this group of patients, acute damage ot heart muscle may be 
pre.WIled to be ppeaent it" there is an elevation ot 500-'1' ln the 
absence of known actlve liver 41sea •• (35). 
Ilnce publonary i.n.fa.rctlon 1. often a oomplioat1ng 
faotor ln the dlagnosi. ot an acute myocardial infarct, an ex-
perimental atudy has been carr1ed out by Agr •• s et a1 (1) to 
determ1ne whether or not acute pulmonary Intarctlon per •• p,.-o-
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due.. signitlcant elevations ot serum transaminase levela. There 
appeared. however, to be no correlatIon between amount of pulmo-
nary Int8.l"ctlon and Increaaea In SGO .. T levels. Furthermore, min-
Imal myocardial infarction ot the order of 5 per cent wa. a •• oc-
iated with greater transamInase rIa •• than found with pulmonary 
intarotion per •• ot the order 01" 45 per cent. Thus it was con-
cluded that thi. stUdy ot"fex-ed no evidence that acute experimen-
tal pulmonary Infarction Is a •• oclated with _ signIficantly 
elevated serum transamina.. level. 
Relation ot" 800-1' Levels to Llvep.Cell Damage 
The relatively high GO-T actIvIty in lIver t1ssue sug-
se.ted that liver cell injury might result In the relea.e ot tbi. 
enz,.. into the clrculat10n comparable with that already reported 
follOWing aoute m1Oc&Pd1al Infarction. None of the lIver function 
te.t. pre •• ntly available provIdes a useful index of the degree 
ot l1ve~ cell injury o~ d •• truotion. Molander and co-workers (45) 
determined the ette.t of Intubation ot carbon t.trachlo~id. on 
the SGO-T level in tbe whIte rat. The actIvity varied. .from a mean 
01' 230 unit. in the control group to a mean ot 2,728 units In a 
group ot animals reeeiving a total do •• ot 1.2 milliliters ot 
carbon tetraohloride during 4 to 6 intubation •• With inoreasing 
degr.e. ot hepatocellu1a:r damage produoed by gastrl0 intubatIon 
of oarbon tetraohlorIde, a.s determined by' both gross and miO:l'O-
800plc studte., hIgher •• rum t~an.am1na .. actlvltl •• a~e noted. 
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The height and duration ot 1ncreased SGO-T aotlvlty was proport-
Ional to the amount ot oarbon tetrachloride adminIstered and as 
well as to the severIty or liver-cell damage (45). Neither .erum 
cholinesteraae nor alkaline phosPhatase seemed to have the same 
degree of sensItIVity that the SGO-T activIty posses.es In re-
tlectlng hepatocellular Injury. Marked aminopherase (transaminase) 
elevations were a180 seen in two patients who were accidentally 
expo.ed to carbon tetrachloride rum •• two day8 before hospital-
isation (64). The level a were 27,800 and 12,000 units, respect-
IVely, 48 hours atter exposure and showed a rapId return to nor-
mal within aeven day •• 
The transaminase actIvity bas also been followed in a 
patIent receiving pyrazinamide treatment tor tuberouloais. This 
patIent developed elevation ot actIvity 3 weeks berol'"Et he devel-
oped ollnlcal or other laboratory evidenoe of toXic bepatitis. 
When the drug was withdrawn the 3GO-T activity returned to normal. 
The fact that increaled act1vity has been round to precede the 
development or Jaundice resultIng from pyrazinAmide and alao 
ohlorpromazine auggeats that transaminase aotivity may be used aa 
a tool to anticipate and thereby prevent toxic hepatitis in 
patients who are receiving potentially hepatotoxio drugs (64). 
In any dlsturbanoe ot 11v81" function, whether due to 
aoute infeotion or to chronic liver disease, where significant 
al'"ea8 ot hepatic cella undergo necrosi8, it haa been found that 
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elevationa ot SOO-'1' may be expected. Measurement of SG·O ... T act ... 
ivlty during the acute phase ot hepatItis, whatever ita cause, 
usually permit. dIfferentiation of jaundIce due to this cause 
from that due to oirrhosi8, extrahepatic obstruction of the bil-
iary ducts, lIver metastases and h&mo118ia (64). In oirrhosis of 
the llver, 8GO-T varies trom normal to 300 units unless oompli-
cating hepatitis Is also present. In extrahepatic biliary ob-
structIve Jaundice, the rise is in an inorement of approximately 
200 un1ts. In proved lIver metastases, the level 1s generally 
fram 80 to 300 un1ts. Wroblewski (64), on the other hand, found 
that in infectIous hepatItis, the levels ranged trom 350 to 1,000 
units and in homologous se~~ hepatItis the levels vnr1ed fram 
500 to 2,500 unite. Molander (44) report. SGO-T levels In patients 
with Infectious hepatitis ranging frorJ 540 to 1.890 units and in 
patients wIth homologous serum hepatitis ranging from 525 to 
3.600 un1t •• 
Fr1end et a1 (21) have reported their observations or 
the eftect ot Viral hepatitis on SGO-T activity in mice. ~~ey 
ob.e~ved that the liver-eell 1njury due to virus hepatItis like-
wise ~ •• ults In an Increase in SGO-T aotlvity which 18 roughly 
proportional to the amount of. inooulum given, to the amount ot 
virus In the blood and to the extent ot histologioal neorosis of 
the lIver. Oe Ritls (18) reports rises In both SGO-T and SGP-T 
levels during viral hepatItis but the 1'1.86 1n SGP-T Is larger than 
1'1 
the SGO-T and tho x-atl0 of 500-'1" to SOP., 1s deer ... "8d. 
The aminopberase act1vity appears to oorrelate .011 
with the ollnloal atatus. Peak levela or am!nopheraae are uaually 
to\.1lld when the pati8Dt 1s slok •• t ... a aan1teated by lethal'gy. 
rever, anorexia. Daua_ and vom1t1ns (64). Conver-•• ly. the pa1t-
lont. beoome more alo" and atebril. and bave htUPDot appoti t. 
abortly .,Zt.- the usuall,. preelpit10U,s tall or $GO-! occur,,_ The 
soo-'t actlvlty does not altaI' 1n the ..... dl ... otlon. magnitude 01" 
time .e any or ~. o~tly employed 11ve1" funct10n teata. There 
18 no cowelation between the SGO-T aot1vlt1 and tho erythrooyte 
aed1118ntat,1on Nte, wh1t. blood con oount. t8llp8ratur8 or 0-
HaCtl YO protetn (85). 'l'be other toet. or 11"8" tunot1on uwal1y 
are abnormal tor day. O)!I .o.le. after tile t:raneaatnan aots. vi t,. 
baa retwmedto n01"llal (&6). 
From the ob.or¥atlon or 40 patl.n'..l tb various aoute 
hepatl0 dl........ l.t appears that ante b.patS.~l. 18 alao ••• 00-
iatri with a ria. 1n ooP-1' acti"lty of' f'l-<.Ia 2 to 1.000 t1._ Ule 
nol'JDal (61) (68). The peale ria. 4urlng the C01.1He ot cUn1cal 
hepatitis 18 roughly proportional to tn •••• er1t7 ot tbe di ••••• 
proo •••• In aout. hepatiti8. the SGPwT aotivity 1. peater thaD 
that of' 8GO-1'. Consequently. the ratio of SGO-T aotivity to SOP .. 'l' 
activity (SGO-1'/SGP-T) taU. fitOlll the normal uan yalue o~ 1.3 
to 0.64 (18) (19). 
The .... a1m1larlty ot SGP-T and SGO-T concentration 
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was .een ln pat1ents wlth extrahepatic biliary ooatructtve jaun-
d1ee. Cirrhosis of the liver 1. a •• oolated wlth inoreased SGO-T 
and SGP.T aotlvlty in whioh the SGO-T aotlvity 1. usually greater 
than the SGP-T actlvlty. Infiltratlon or the llver by leukem1a or 
lymphomatous di ••••• may alter the SGO-T but haa not been .een to 
cau •• elevatlon ot the SGP-T aotivity above tbe normal range (67). 
It appear. that sao-'lt aotlvlty 1. a more aenalti"e n-
flection or ohronlc hepatic di..... and that SGP-T ls more readi-
ly el.".t.« byaoute hepatltis (67) (68). By the simultaneous 
measurement of 800-1' and SGP-T lt may be po.alble to d1fferentlat. 
acute from ohronlc ltv.p-o.ll damage. SOP.If, unllke SGO-T I has 
the added advantage of USUAlly not belng appreclably elevated by 
aoute myooardial infarction except in the presenoe of' extensive 
myooardial neoroal •• 
The pre.ence 1n hepatlc tlssue homogenate. or consider-
ably 1 ••• GP-T than GO-T sugge.ta that the r81atlvely gr.ate~ In-
crement ot SGP-T aotlvlt7 in aoute liver diee •••• oould not be 
solely due to rele ••• ot the enB,me from necrotic hepatic tissue. 
Variation. in the relea.e, destructlon or excretion or the two 
ena,..s or an unknown aberration ~. probably Important contrib-
uting meohan1 ... and b&"e yet to be clarifled (6'1). 
The natural uncomplicated oourse of infectioua hepatltl 
1. a.aociated with a gradual rl •• 1n SGO-T actlvity to a peak, 
followed by a gradual deore ••• ln .erum enz,.. aotivlty toward 
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the normal range during the recovery phase. When In~eotion. or 
other oompllcations ~oour during the oourse of hepatItIs, the 
added stress tends to influenoe the hepatitis and this i. re-
flected 1n a aecondar,., superimposed rise in SOO-T actIvity (63). 
Ambulatlon durine, recovery from Infectious hepatItis 1. 
sometimes asaoolated wIth a small secondary rise h'l SGO-T acti vi t, .. 
If the riae following ambulatlon 1s 50 or more unIts, return to 
r8st dIscipline appears advisable, and SGO-T activity usually 
resume. its return toward normal. Assooiated with the seoondary 
rlse due to ambulatlon are uaually reappearance of malaIse, hep-
atic tenderness and right upper quadrant pain which also disappear 
a8 the SGO-T returns to normal. 
SGO-T elevat10ns above the normal range read1ly permit 
the detection of acute hepatlt1s in the asymptomatic or prodromal 
phase after exposure to infection (63). The SGO-T level may con-
tinue to ria. tor 50 to 60 days prior to the onset of nausea and 
anorexia, during which time the other liver funotion testa may 
remain normal. Th1a would sues.at that measurement of SGO-T ot 
all contacts during an epidemic would permit differentiating 
those indiVidual" who mny develop infectious hepatitis from. tho •• 
who are to remain well. ~he tormer group eould then be prophylac-
tically treated with immune globulin without unneeeasarl1y ad-
min1ster1ng this material to the larger group with normal SOO-1 
who are not potent1al oandidates for acute hepatit1s. 
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The transaminase test bas been of uae In evaluating the 
signifioanoe or alkaline phosphataae elevation (66) sinoo the 
5UO-1 level 18 normal when the phosphatase 1. elevated a8 Q ro-
tnut ot bone d1..... or bono meta.ata... but rlses when conoom-
itant alka11ne phosphatase elevatlon 1s due to liver d1seaso, In-
cluding liver •• ta.ta •••• 
Hudolph (56) has reported .levations ot: sel'Utll glutamic 
oxalacetio transaminase rol~owlns experimental infarot involving 
kidney, spleen, lungs and bowel. It 18 evldent in these studl •• 
that nocr0818 ot many types ot tIssue. results 1n elevation of 
SGoJr. Aa the amount of tissue rendered necrotic is reduoed, the 
amount of en.,.. appearing in the peripheral oirou.lation is com-
mensurately l •••• n.d and may £&11 within the normal range. This 
ls tru.e a.lso of ischema. ot ahort duration. 
In anoth.~ .et of experiments D7 Milch and Albaum (43), 
rabbit. woro expos.d to A-irradiation in dOBages of 500, 150 Qnd 
1,000 r. A significant increa.e in SGO-T could be identified at 
6 hours in the group subjected to 500 r and as early as 3 hours 
post 1rradiation 1n the 750 and 1,000 r groups. No relation waa 
found. between S60-'1' elevation and surv! val time so 1 t would. seem 
that survival depends, in the main, on the animal's ability to 
overcome and repair the insult. 
In aumm.ary, the determination 01' SGO-T aotivity seems 
to have great pot.ntlal value in the eatimation of the extent or 
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tissue necrosis in myocardIal infarction and acute and chronio 
hepatitl. since the peak levels or 800-T elevatIon approxim.ate 
the tissue damage. It is a useful tool in diagnosing myocardial 
Inta~~tIon In the presence of chest paIn which may be due to 
chronic oongestive cardiac tailure, angIna peotoris, aoute pul-
monary infarction at cetol'a.. Levels of SGO .... T over 350 units 
aooompanying a myocardial infarction carry a grave prognosis. 
'l'he SGO-'r teat 1s a useful tool for distinguIablnt,; Jaundice due 
to hepatiti8 from that due to cirrho81a, extrahepatIc obstruction 
of the biliary duots. liver metastases and hemolysis. It may also 
be a means ot predetermining which ind1viduals exposed to hepatit-
1s will be afflicted with the disease and also a tool to antici-
pate and thereby prevent toxic hepatitis in patients who a~. re-
cel'11ng potentially hepatotoxic drugs. 
Serum glutamic oxalacetlc transaminase elevations above 
the normal level have not been .e.n in patIents with Inrectloua. 
neoplast1c. metabolic or degenerative diseaaes in which acute or 
chron10 de.truction ot heart, skeletal MUacle. live~ or one ot 
the other transaminase rich tissues could be excluded. 
The enzyme glut ami 0 oulao.tic trtUl.$amlnaae 1s II. nor-
mal oomponent ot the aerum. proteins _ but :n..s been found to be 
oons1derably elevated In certain patholo~lcal state. involvIng 
primarIly cardiae muscle ~ld 1lve~ tissue. The ~ec.nt develo~t 
ot a 8impllf1ed, accurate and tairly rapid speotrophotometrio (26) 
method for the ,determination 01.' the enz,.. In serum has led to 
enhanoed intereat In the clinIcal implications ot increased 
le"els ot the 8n~yme &hove the nqttmal. The ourrent work being 
reported In the literature deal. ~lmaPl1~ wIth attempts to 
correlate the e1o.,..ted SCO-T l.vele with degroe of: tissue damage 
due to aoute myocardial infarotion 01" to 11v.,,-0811 injury 
cauaed by homolo£oua •• J'UllIl, infecttous or toxio hepatItis, otrr-
hosla 01" canoer. In spite or the clInIcal interest 1n serum 
Glutamio oxalacetia t~ansam1na8e, little tUlldamenta1 blochemioal 
work haa been 1"epoJ'ted on this serum protein to date. 
Tb1s reaeareh deals with an attempt to pre.ent a fur-
ther bloohemical oharacterizatIon ot the enayme tram the point 
of vIe. ot it. 91eotrophoretle m1gntlon pattern, 1 ta t!'&otlonal 
precipitation properties and the nature or the linkage between 
the enzyme and ita oo.n~Jm., pyridoxal phosphate. 
In determln1nc the eleotropboretio pattern or 8erum 
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glutardo oxalaoetic transaminase, the .8l!'Ullt proteIns of·the 
whIte rat "eN •• paNted lonographlcally into disoz-ete banda on 
tiltep paper atr1p. usIng the Prec1s1on type tonograph (39). 
The bands were then out from the strIp and the proteln fract10ns 
eluted f'rom the filter paper with a phosphat. butfer solution. 
Each of' the eluted sample. was then analy •• d tor transaminase 
act1v1ty by the speotrophotometr10 prooedure d.8Cl'ibed by Karmen 
(26). 
It haa been sugge.ted that the linkage between the 
enz,.., glutamic oxalacet1c transaminase, and P'11'idoxal phosphate 
1. ot a non-1on1c nature due to the un1versally exper1enoed 
diffIculty 1n resolving the enzyme into apoenzyme and co-enzyme 
and to the requirement for relat1vely prolonged preincubation 
periods between co-enlyme and apoenz,.. tor activat10n ot the 
vitamin Be-enzyme (42). In this roe •• arch an attempt was made to 
determine it the protein band containing the maxImal transaminase 
activity was tully saturated with pyridoxal phosphate and it the 
position of maximal aotlvity on the paper strip would be altered 
by the addition ot the co-enzyme to the spectrophotometrio reac-
tion mixture. 
In the traotional preoipitation ot the .e~ prote1n., 
to determine w1th whICh traction the transamina.e aotlvlty was 
assoclated. the protelns .ere removed trom solution by the pro-
cess known aa "saltlng out". The albumin and globulin traction. 
wore separated by salting out wlth ammoniw.1 aulfQt. and· the 
fraction. were tested tor transaminase aotivity by the spectro-
photOl1et~lc method. of Karmen (26). 
CHAPTER III 
THE :6LECTfWPUOhE1'IC MIOHA~J.lI<i:i PA'l'TERN OF SEH!J!t1 GLUTAiUC 
OXALt1.GETIC ~:IUU1SAMINA~S 
I'rom Chapter I. it has been seen that the concentratIon 
or serum f;lutamio oxalaeet1c transaminase correlates well with 
the degree of' myocar<.l1nl infarction. Also, in persons with coro-
nary atheroacleros1.s. or with d.t.eases predisposing to a.thero-
solex-os18 (diabetes, nephros1s), there 1s a tendenoy to the re-
duct10n ot" albUI'n1n and alphfl lipoprotein and a relative and ab-
solute increase 1n beta lipoprotein (30). In a report made b,. the 
C omm1 ttee on Lip1d and Lipoprotein l101'll.nelature or the Ameri-
oan Soeloty for the Study of Atherosclerosis (8), it was suggost-
ed that the te~8 alpha and beta 11po~ot.In8 be restrioted to 
lipoproteins w1th electrophorotic mobilIt1es of the alpha and 
beta globuUns of the eel'Um, respectIvely. Slnoe there Is an 
increa.e 1n the concentrat1on of the p~otein, ~10-T. 1n Myocard-
lal infarotion and an 1nOre&8& in the beta lipoprotein fraction 
or the ser-am lipoproteins in coronary atherQsolerosis, it was 
thought that the SGO-T might 1n some way be associated with the 
b6tn globulin fraction ot the se~ proteins. In order to study 
the electrophoretie pattern of SGO-T then, the electrophoretio 
separation of the serum proteins in a paper stabilized medium 
was selected a8 the tool to be used sinoe it has became a widely 
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utilized and useful aoans of studyine these p~otoins in both 
normal and pathologioal states. 
Qholce ot SamRl~ 
Slnce, 1n eleatrophoretic separations in a paper 
stabIlIzed medium. the sample size 1s great1l limited, partic-
ularly if pap.r strips are used, samples contain1ng relatively 
high concentrations o£ ~. enzyme are desired. It has bean aeen 
that the enz,.. 1s in greateat conoentration in the serum during 
pathologies involving ntlarosia of transaminase-rich t1ssues. These 
serum. samples .ere not readily available. however, and sinc. 
normal h.urJan serum 18 rela:tively low in transaminase aotlvity. 
with a range of 8 to 40 units and a mean of 22.1 units (standard 
deviation of 6.8) (33) (45), It was neoe.aary to obtain samp16. 
from another sourc •• Fortunatel" for exper1~.ntal purposes, tne 
SGO-'.r a.ctivit,. bas been found to be spec18. speoific and in rat. 
the normal varies from. 1'/0 to 350 unit. (45). while in th .. :mouse 
it varies between 50 and 125 unite (21). Oonsequently, it was 
decided to U8. white rata as the source ot serum samples sinoo 
the,. .... r. readily available and eaaily .. 1ntained. 'l'he rata u •• 4 
as a.rum donora .e1'8 maintained on PurIna }o'ox Chow and no regard 
was taken tor the fasting state prlor to taking the blood sample •• 
Method of ~am.Phin& 
The ooncentration of glutamic oxalacetic transaminase 
1& the same in .erum and plasma. but 1s up to ten t1r.185 !:~.&ter 
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in samples containing hemolyzed red blood cells (27) (33). The 
s~~ples used In this Investisat10n ware serum samples since they 
were more easily obtained than plasma. Blood samples (3 m1ll1l1te~~ 
in 8ize) were obtained by heart p-unctures on ether anesthetized 
white rats, using a Gold SeQl. 5 co. syringe (i>i7373) and a 1 inch 
Yale stainless ateel needle (No. 13-1> 20). The samples were allowed 
to olot at room temperature for approximately five minutes and 
then were oentrifuged for ten minutes at approximately 6500 r.p.m. 
1n the International Clinical Centrlruge (No. 24859). The clear 
supernatant serum was then decanted and hemolyzed samples were 
discarded In order to keep the conditions as constant as possible. 
The serum samples were tightly stoppered and. stored In the refrig-
erator at SoC. unt1l application to the paper strips. The enzy.me 
1$ quite stable and no change haa been noted in transaminase act-
ivity in aerum sruuples stored at room temperature tor as m.uch as 
four days (27) (34) (57) or for periods of from one hour til two 
weeKS in the refrigerator at O_SoC. (27) (33). l~e unexpected 
stability ot this enzyme was evident from observations that were 
.made by Sobel (57) on 2 groups ot samples, each group conSisting 
or 2 samples ot normal sera and one sample ot serum with an In-
creased level of transaminase. One group was kept at roam temp-
erature (apprOXimately 25°C.) tor 19 days and, although there was 
a oonspicuous growth of bacteria, no significant decreaaG was ob-
served in tne transaminase activity. The other group ot 3 sample. 
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was incubated at 37°<.;. 'rhere was a decrease or 30 per cent ot the 
activity in one sample within 3 days. whereas the other two had a 
loss of only 7 per cent ot the activity in 9 day •• l~e activity 
of transaminase at 37°0. i8 approximately doubled that at 25°C. 
(25). The transaminase aotivity is not changed by freesing or lyo-
philization ot the aerwa (27). lio change in aotivity was noted 1n 
aera subJeoted to 560 e. tor 26 minute. (27). Sera heated to 100°0. 
for ten minutes were found to have a deorea •• in activity to ten 
per cent ot the original activity (27). Although the transaminase 
aotivity bas heen round to be remarkably stable, it was round 
that the ionograph1c patterna were increasingly more indistinct 
a8 the seru:m aged. The mobllitie. decreased and the bands .... re 
cons1derably less d1stinct slnoe there was more amearing 1n the 
samples stored at 5°C. tor more than tlve days. Consequently, 
serum samples more than three days old .... re not used for the 
electrophoret1c separat1ons. 
Var10us sample alzes were run electrophuret1cally to 
asoertain the largest volume of serum that could be separated 
and stll1 giva clearly defined bands. The sample sises tested 
were 1, 2. 5 and 10 micro11ters. While the 2 microliter sample 
would have been the choice had soannlng ot the lonograms been 
nece.sary, the 5 microliter sample gave very distinct patte1"ns 
upon v1sual observation. Samples larger than 5 microliters gave 
very 1ndistinct patterns due to smearing, probably caused by the 
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1arb6 amount 01' albumins which were present. Dial:;sis ot the 
serum against butl~er did not seem. to be necesaar:.r since the pro-
tein bands were already 018&1'11 defined with the sample size used. 
'l'he IQn0.sa:aPhj.c SeRaratloa of £40 Strum. Proteins 
The apparatus used in the sepnrt.ttion of the serum pro-
teins 'flUS the 1onograph ll'ls.nu1"actured by Precision Scientific Com-
pany. Chicago, Illinois. Tuo PI'ototype of this apparatus and the 
experim.ental technique employed in its operation have been des-
cribed in detail by MaVoIlald. at al (37) (3a) (39). The temperature 
ot the system. wa.s t1aintained constant at :25°(;. throU;?).lout all run. 
by oiroulating water trom a constant temperature bath thrOll.gh the 
apparatus. The materia.l used 'UI th.e stabIlizing medium was Whatman 
No.1 filter paper (one-half inch in width) (7). 1~e butfer syste. 
used was varonal (.:iiethylbarbiturl0 a.cid and sodium dlethylbarbl-
turate) of ionic strength 0.0'7, pH B.ag at 2SoC. and a. total con-
centration ot 0.0772 molar (Appendix). Trial runs were rr~d~ using 
veronal butfers of ionic strencths varying from 0.03 to 0.07 in an 
effort to det~rm1no tha lowest ionic strength at which satisfaot-
ory aeparations oould be made. At the lower ionic strengths, the 
separations were more rapid but there was inoreasingly greater 
diffusion as the ionic strength was reduoed. The conditions out-
lined above seemed to be optimal tor the type of separations de-
sired althOUGh the ·iJimo necessary for the separations was increas-
ed. A water saturated. hellu...'11 atmosphere was lualntained in the 
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chamb~r or the tonograph in order to di.sipate tho electrical 
energy developed in the strIps and to mln!m1ae the 10.. ot water 
by evaporation (39). The method of tonography u •• d was the hori-
zontal strip method described e~l1er by McDonald at a1 (39). 
The strip. (31 centlmatera 1n length from bufrer to 
butter) were saturated with the veronal solution prior to being 
plaoed in the lonosrap..~. A one hour equ1Ubr-atlon time was maln-
talned under the same condItions ae the run 1tselt before the 
aerum _.p18. .ere applied to the oenter of the paper strip. A 
potent!al of 4.8 volts per oentlmotar was then applIed across to. 
strips oonta1n1ng the m1({;rcmt to'!! a total of 7 ho1..lrs. Hoth the 
leacUns edge and the trail1nr; ed&e of the vulou. protein band • 
•• ra mea.ured. Under tn. cor~tlon. desorlbed, the names of the 
protein ~ildS starting with the one furthermost f'roa the point ot 
! 
application and 1n the direotion or the positive pole are albumin. 
alphal-~l.bulln, a.lpb.a~t·'Slobulln and hota globulin. The gut.:u! 
globulin t1"actlon moves toward the negative pol@ under these con .. 
41tlona <,f). It plasma samples had o.8n 1180d there would have been 
.'tlb:rln(),en band between the bets. and gamma gloouUns (6). Tho 
~.tano •• J:lov.d by the various protein traotions are given ln 
table I. 
! 
Arter the saven ho~ separation. the str1ps (7 in num-
;)01') wero X"OtaOved from the lono~uph and dried ut a tom:pevaturo 
not exoeoding 3"oC. '111 th a aarvol Hair Dr;,"er, Yodel Br'H-25. manu-
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TABL'E I 
DISTANCES MO~'D (in centimeters) HY THE SERUM 
PROTEIN FRACTIOIS UNDl-::R Tft..E COIDITIOlIS OJ<' T'ai~ 
:EXPERIYENT 
. , 
a_pl. t(WIlbel' 
Protein Fraotiona 1 2 a 
" 
I) 6 fl Ave. S.D. 
Albumin. 
Loa4100 Kd~ 4.3 4.6 4.3 4.3 4.4 6.5 4.2 4.4 .t 0.14 ~ll1rig E 3.3 3.8 3.5 3.' 8.7 3.6 3.4 3.5 + 0.18 
-
Alph~-globulln: 
LeadltlG Edge 3.0 3.8 3.0 3.0 3.8 3.1 3.0 3.1 + 0.14 
Trailing E4ge 2.5 2.6 2.6 2.4 8.6 9.6 I.' 2.6 i 0.09 
A lpba2-g1obul1n a 
I._cling ~ a.o 2.2 1.9 1.9 a.o 1.9 1.9 a.o .1 O.lS 
TJltall1ng E • 1.3 1.4 1.4 1.2 1.6 1.3 1.3 1.3 ± 0.11 
Beta globuUnl 
Leading Ed;e 0.9 1.0 0.9 0.9 1.0 0.9 0.9 0.9 + 0.06 
TralUng EdS_ 0.3 0.4 0.4 0.8 0.4 O.S 0." 0.4 i 0.07 
G_ elobul1rn 
*' -1.4 -1.3 -1.2 -1.4 -1.2 -1.2 -1.2 -1.3 .%. 0.10 Leading Edge 
'l'Z'a1Uns Edge 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 + 0.00 
-
* Negative sign indioate. migration toward the negative electrode 
in the tonograph. 
S.D •• Standard Deviation. 
tactured by M1ma.r Products, Inc., Brooklyn, New Yo~k. One str1p 
from eaoh set ot seven strips was then stained tor prote1n with 
a Bram Phenol Blue solution (Appendix), the color developed by 
washing the str1p 1n dilute aoet1c acid and the aold removed by 
washing 1n dist1lled water. This strip was then dried in an oven 
at 9900. and used aa a reterence to locate the protein bands on 
the other 8ix remaining str1ps. The areas corresponding to the 
prote1n bands were then cut tram the str1p and atter a total at 
ten runs on the 1onograph the bands .ere combined, making a total 
01" 8ixt,. bands per prote1n traot1on. Since 5 m1c~o11ters 01" .erum 
had been applIed per paper at~ip, this oombined sample r.p~.8.nt.d 
the prote1n traotion tram 300 miorol1ters 01" serum. Each of the 
combined samples was then balanoed against an equal we1ght or the 
filter paper, out tram a section 01" the filter paper strip out at 
the range of tn. migrating proteina, whioh was used as the con-
t:rol 1n the sub.equent apectrophotometric analysis. Both the pro-
tein bands and the oontrols were then eluted. with 0.1 M. phosphate 
burter ot pH 7.4 (Appendix). The eluate was d11uted to 3 milli-
11te:rs with the phosphate butter. The sample was now ready tor 
analysis ot transaminase activity by the speotrophotometric method 
described by Karmen (4) (2a). 
Suctr2pholcetr,le DetemeaticD ot 'rrag8!!!!naae Act1vitZ 
In the spectrophotometric •• thod, 0.5 ml. of 0.2 M. 1-
aspartate (Appendix), 0.1 ml. ot a buttered solution of malic de· 
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hydrogenase, 0.3 mi. of a buffered solution of reduced dlphospho-
pyridine nuoleotlde, 1.3 ml. of the sample solution and 0.6 ml. 
of 0.1 M. phosphate butter were incubated tor 30 minutes at room 
temperature (appro~lmately 25°0.) in a 3 co. 81lioa absorption 
cell. The referenoe cell contained the same components as the 
sample cell exoept that an additional 0.3 ml. of 0.1 M. phosphate 
bufter solutIon was subst1tuted tor the 0.3 ml. ot reduced Co-
enz,.. I. The control was run exactly as the sample. Arter the 
tb1rty m1nute 1ncubation period, 0.2 ml. ot 0.1 M. alpha-keto-
glutarate solut1on (Append1x) waa added to the react10n mixtures 
1n the 3 ec. cuvette. and the rate ot deereaa. of opt1oal denaity 
was .easured at wave length 340 mil11miorons over a thirteen 
hour period on the Beckman DU Speotrophotometer, Model 2400, 
Serial No. 130423, wIth a Sorenson Power Supply, tfNOBA'J.!RON" MA-
6501, and a Beekman Hydrogen L~p Power Supply, Model 2965, 
Ser1al No. 118133. The rate ot decrease ot opt1cal denslty ls 
taken .s a meaaure ot the transaminase aotlvity. 
Auto-oxidation of the reduced dlphoaphopyrld1ne nuc-
leot1de takes place durIne: the th1rteen hour l"\Ul as aeen from 
the graph ot Figure I and Table V (Appendix). The solld 11ne in 
Figure I repre.ents the spectrum of a solution contaIn1ng 0.3 ml. 
ot reduoed Coenzyme I (approximately o.a mil11gram per milliliter: 
and 2.7 ml. of 0.1 M. phosphate butter in the cuvette •• The dottec 
line represents the spectrua ot the same solution atter thirteen 
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hours. ~~a auto-ox1dat1on 1s compensated ~or In the expe~1ment 
by the control which Is !'Un with each protein sample, hoff.ver .. 
and the d1r~e~enoe between the decrease In optIcal density of the 
sample and that of the control (designated here as "actIvity 
unitatt ) 1s taken as the measure of the act1vlty present in the 
.samples. Thi8 .ethod 18 a modIfIed version ot the one deso-rlbed 
by Karman (4) (2S) tor the determination ot SGO-T in serum. 
The reaotion was carried out at pH 7.4 as a. result ot 
the finding ot maximal activ1ty tor saO-if between pH 7.0 and 8.0. 
wb1ch 1s in agreement with the results of Cohen (13) and others 
using pig heart ~cl. a. the source ot the ensyme. It was con-
ducted at roam temperature ot approxImately 25°0. tor convenienoe 
even though the aot1vIty 1s practlc.lly doubled at 31°0. (25). 
The 30 minute Incubation perIod was ma1nta1ned due to tho r1nding 
by Karmen (a6) that when reduced Coensyme I 1s added to serum 
wIthout additIon Gt substrates, the optical density of the m.1xture 
deore.... tor s1x to Beven m1nutea. indicating the oxidation or a 
fInite quantIty of reduced Coenzyme I. Atter this reaotion haa 
stopped, completion Of the transamination sy.tam results 1n a 
steady deorease in optIcal density • 
.Karman found that the rate or amount of DPNH oxidation 
by serum alone 1. not ehanged by the addition of malie dehydrog-
en .... and e1ther l-aapartate or alpha-ketoglutarate (2S). The 
amount oxidized. 1s not apprec1ably affected by adding more DPlm:. 
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a .. alao round that the addit10n ot 0.2 ml. ot pota •• lu.m.p;rruvate 
(4mga. per ml.) atter th1. reaotion baa stopped, reau1ta in com-
plete oxidation ot the DPNH pre.ent at a measurable rate, demon-
stratIng the pre •• noe ot laot10 deh,.drogena.. 1n ael"UDl. Dialysi. 
or the serum against 0.1 M. phosphate butter reduoe. the amount 
ot DPNH ox1d1.ed w1 thout ohanging the .eaaUJ'able transam1nase 
acti '1'1 t1 ot the .erum, Indioati.ng a 108. ot pyruvate b,. the .el"Wl. 
during the 41al,.si.. Karman has theretore suggested that the oxi-
dation ot DPNH by .erum alone depends on the pre.ence ot pyruvate 
and lactic dehydrogenase 1n the .erua. The reaotion atopa when 
all the pyruvate 1. enzymatioall,. reduced to laotate by DPNH (26). 
i 
Omitting malic dehydrogenaa. trom otherwi •• oomplete 
transaminat10n reaotion mixture. re.ulted in a variable decrea •• 
1n the ob.e:rved rate ot DP~nI oxidation. That the l'eaction ••• 
atl1l meaaureable waa taken a8 .uggestive evidence either tor the 
pre •• noe of maUc dehydl'ogena.e in .el"UDl or tor the decarboxy-
lation ot oxalacetate to pyruvate and subsequent DPNlI oxidatlon 
by lactio dehydrogenase (26). Addltion ot more malio dehydrogen-
ase to any •• rum transaminase a8S&1 re.ulted in no further in-
crease 1n the measured rate of reaction, ind10ating that the 
ane,.. was pre.ent 1n exc ••• in the ••• al mixture. 
Study or the variatIon of SGO-T aotivity with substrate 
ooncentrat1on Indicated that maximal actIvIty was obtained when 
the 3 milliliter reaotion mixture contained more than 50 micro-
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mol •• of I-aspartate and 5 m1oromole. of alpha-ketoglutarate. One 
hundred mioromoles of l-aspartate and 20 micromole. ot alpha-keto-
glutarate were used in subsequent determinations (26). 
The reaotions ot both the sample. and the oontrols .ere 
followed over a thirteen hour period by measuring the deorea.e in 
optical densIty a8 the reduced dlphosphopyrid1ne nuoleotide 1s 
oxidized. The 41tterence between the deore.s. 1n optioal dens1ty 
ot the sample and that of the oontrol was taken .s the transamin-
as. aotivity and d.s1gnated a8 "aotivit,. units" 1n l"~1gure II. The 
deorea.e 1n opt1oal density attributed to the various prote1n 
tractions are likewise tabulated 1n Table II. 
As oan be seen trom jiligure II and Table II, 80me reduot-
ion in optioal density 1. brought about by all of the traotions 
teated. Thia reduotion may be due to a protein ettect on the DPNH 
or to the pre •• noe ot small amount. or tran.amina.. in allot the 
tract10ns. 'rhe enzyme .tteot i8 seen to be ooncentrated in the 
are. ot t~ alpha2-g1obul1ns .nd the a.e. 1mmed1ately tollowing 
this prote1n traction. The activity in the tractIons behind the 
are •• or maximal aotivity may b. due to adsorption or the en.,... 
to the tl1ter paper strip durIng the prooe8S or electrophoresis. 
The aott "11 t7 1n the area. preceding the alpha2-g1obuUna 8y be 
due to some ot the enzy.me being more or le.8 swept along by the 
large bulk ot albumins pre •• nt 1n the .erum. 
Contrary to expectation, relatl"18ly little of the trans-
TABLE II 
TRANSA:4INASE ACTIVrry OF 1'1m VARIOUS SERU14 PROTEIN 
F'RAGTIONS AFTER THIRTEEN HOtfRS 
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Decrea •• in 02tical Density 
Protein }'ractionl 
1. Albumins 
1 2 3 " 5 Ave. 
0.025 0.150 0.066 0.012 0.032 0.057 
2. Albumin to Alphal 0.025 0.056 0.048 0.014 0.011 0.031 
0.030 
5. AlphaS 0.119 0.187 0.081 0.151 0.037 0.115 
6. Alphaa to Beta 0.194 0.072 0.086 0.348 0.092 0.158 
7. Heta 0.050 0.054 0.037 0.127 0.024 0.058 
9. Q.amm.a 0.013 0.027 0.021 0.041 0.010 0.022 
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amin&88 aotivity was found to be conoentrated in the beta glob-
ulin traction ot the serum proteins. Thu8, there apparently ex1ata 
no correlation between the increased beta lipoprotein levels in 
athero8clerosia and elevated .erum glutamio oxalaeetic transaMin-
.se level. in myocardial infarctions. 
CHAPTER IV 
COENZl'lm El"f'ECT ON TRANSAMINASE ACTIVITY OF IONOGRAPHI-
CALLY SEPARAT~D SERUM PROTEINS 
It haa been stated that most of the amino aolda wl11 
undergo the tran~1natlon react1on. Herbst (24) haa reported 
that enzyme catalyzed transaminatton reactiona proceed only If 
one ... ber ot a transaminat1ng pair 18 a d1carboxy11c amino or 
keto acid. Pyridoxal pho.phate haa been shown to act as coena1Jl1e 
1n tranaaminatlon reaotions (22) (46) and OtKane and Gunaalus (52) 
have determined the ooens,... saturated C\1PYe •• 81s'31", Sobe". and 
Peterson (40) bave found that both pyrIdoxal and pyrldo:um1ne 
phosphat.s aot &8 ooenzymes tor h.art llpotranaamina •••• The •• 
lnvestlgato!'s found that simultaneous m1x1ng of" P1PIdoxal ph08-
phat •• ensyme and substrates r •• ultea in low aotlvlty, and that 
pre.inoubatlon ot ensyme and pyrldoxal phosphate was necessary 
for appreoiable actlvatlon with low ooncentrations ot pyridoxal 
pho8phat •• For pre-inoubation periods ot 1 ••• than one hour, 
pyrldoxal phosphate actIvated the tran.amination reaotion signifi-
cantly more than pyridoxamine pho8phate, but upon longer periods 
of pre-Inoubation. equivalent aotivtty was observed with both 
phosphate •• ter. at the same conoentrations. The data are con-
slstent with the hJPOthesi. that aotivation require. enz,me-
ooenzyme combination <40). The requlrement for relatively prolong-
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84 pre-incubation periods between coenzyme and apoenzyme tor 
activation of the various vitamin Bo enzymes sUggests the pre-
sence ot aome type ot non-ionic linkage (42). The universally 
experienced difficulty in resolving the.e enzyme. into apoenzyme 
and ooenzyme a180 18 consistent with the formulation of nonion1c 
linkage. (42). 
The mecnanism ot aotion ot these coenzymes i8 not 
detinitely established, and a pure transaminase baa not yet been 
isolated (46). The beat preparat10n 1& probably that of Cohen 
and Cammarata (10) (11) who report that low temperature aloohol 
fractionation appeared to of tel' some advantages OVel' the arnmoniUDl 
sulfate tractionation proced\1re which yielded a p&.l"tIal11 or 
completel,. :relolved product in low yield. This preparation ot 
Cammarata and Cohen contained s8vera1 metala" however. 8.S judged 
by emis810n spectrography (46). However there ••• m8 to be good 
eVIdence (42) (46) that in transamination, the pyridoxal phos-
phate forma an intermediate Sohitt bas$ with the amino aoid. Th1. 
intermediate is then p~esumed to decompo.e into the corresponding 
keto acid and the amine tor.m ot the ooenzyme. 
Snell and his assooiatea (42) (46) have found that 
oerta1n matals (oupric. ferrio and aluminum ions) aotivate non-
enzymatic tl'ansamination with pyridoxal phosphate. The reaction 
require., in addition to the metal, the presenoe of the tree al-
dehyde, phenollc hydroxyl and ring nitrogen in the pyridoxal. 
They augSeat that the formyl group funotions 1n \he formation of 
a Sohilt bas. with tn. tm1no acid, tn. latter intermediate being 
stabilised to the nece.8u-y degree by ohelation with the catalJtlc 
metal ion via the nitrogen of the resulting aaometblne linkage, 
the phenolio group and probabl,. \he carboxyl ~u.p ot the IlUI1no 
actd re.idue (42). 
The.. non-en.ymatlo r'fIaotlona oorre.pond .erry 010 •• 1,. 
to the ."''1JI&t10 Hactlonl 011..,.1,..84 by 'dtudn Be protetna and 
1t baa been .a ... d by Snell et a1 (42) that the latt •• prtOoeed 
by a I1J111al' uobard. ... 'the "qui....,.' or .tal lons tw non-
enz,...tl0 traneaainatlon augg •• '. that suoh tona may Uk .. t •• be 
.... ntl&1 tor the en.,mat10 reaotions, but only limited indicat-
lon. or th1. ba •• been obta1ned to date, and It ls polalble tbat a 
ponton ot the p1"Oteln ena,.. 1 , •• It oould tulflll the role p)a;ted 
by .. tal lona 1ft ttut non-ena,.a.tlo r .. ot101'l. It 1I8tal Ions a •• In-
volve4 In the _ • ..,...t10 ",eaotlon. the unocoupled ooO!'dlnatlon poa-
1tlona ot the ..... 1 ohelate. tOl'ftllate4 by Snell (4a) oould be 
ocoupied b:r sroup. from the Gpoen • .,... thu8 turnlah1ns a common 
tl. between apoena,.., o~n.,.. and substNte. 
Many dirt_en' reaotiona ot a.mino aold. aN oatalyzed 
b7 p~14oxal Phosphat. containing enaymea. Most ot tho.e ensymatl~ 
..... tton. ba.e befm dupUoated by rlOn-4tns,..tl0 model "aotlons 
(e.g. deoarbox11atl00a) 1n wh1Ch pyridoxal O~ o\he. appropriate 
a14ebyde. and a sultabl ... tal e.1s •• py ••• oatalyets. It tbua 
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s .... that the catalytlc potentlalitles or pyrldoxal phosphate 
enzymes are to a large degree tho.e ot their prosthetI0 gr-oup 
and that the non-enzymatl0 and enzymatl0 reaotlons proceed by 
clo.ely similar mechaniams (42). 
In Chapter III, It was •• en that the greatest portlon 
of the SGO-T aot1vlty was concentrated In the areas ot the alpha2 
globuUna and 1n the area immediately t,ollowlng thi •• erum pro-
tein traotion. The Q.ue.tion aro.e aa to whether the act1vit7 1n 
thi. tMctlon wa .• due to the ena,.. 1t.elf 01" whether perhaps the 
enzyme had been .eparated tram the coenzyme during the proce.. ot 
electpophore.la. ThIs might well be the oa.e 1t the bond between. 
the enayme and tbe coenzyme were 10nl0 in nature. It thIs .ere 
aotually the 0 ••• , the actIvity round 10. the area of the alphas 
globulins might .ell be due to nan-enzymat10 transamination by 
the pyrldoxal phosphate which could have migrated to this posit-
100. and the ena,.e might be 1n another fpaction, but Inaotivated 
by the loa. of the coenzyme. It waa then decided to add pyr1doxal 
phosphate to tn. eluted t~aot1onB and determine if any of the 
other ttt'aotiona would show slgni1'lcantl,. Increased activity by 
activation or the apoenzyme w1th tn. coenzyme. 
P£!P!£~ti2D .of tao Syple 
In this experiment, the electrophoretio .eparations 
.ere ca~ried out by the same method and under the same condition • 
• a d •• cplbed in Chapter III. In thi. oaa., however, the elution 
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was carried out with a solutIon of 0.1 M. phosphate bUtter con-
taining the coenzyme, pyridoxal phosphate. Sinoe the preincubatlo~ 
time tor the apoenzyme and the ooenzyme have been shown to be 
oritlcal, the serum protein tractions which were eluted with the 
phosphate butter solution oontaining pyridoxal phosphate .ere 
allowed to ~e-incubate tor one hour at room temperature as pre-
scribed by Meister, Sober and Peterson (40). This pre-incubation 
ot one hour was round by these authors to be necessary tor full 
aotivation ot the enzyme. A turther pre-incubation ot ten hours 
In the refrIgerator at SoC. was al1owe4. The enzymic actIYity ot 
the pre-incubated samples was then determined by the atoremention-
ed spectrophotometr1c procedure. 
Due to the non-enz,matic transamination by the pyridoxal 
phosphate and the low c'onoentratlot1 ot transaminase in the protein 
fractiona, several experiments had to be done to det.~lne the 
proper concentration ot pyridoxal phosphate to be used In the 
alution solution. Solutions oontaining 10 and 1 miorograms o£ pyr-
1doxa1 phosphate per millIliter ot solution, respeotively, were 
teatad but the non-enzymatio transamination was so pronounoed that 
the enzymatic activIty was completely masked. The aotivity o£ all 
of the tractions was greatly, but inoonslstently increased and the 
results were not reproduoible. The oonoentration ot elution solu-
tion tinally deCided upon was 0.08 micrograms pyridoxal pho~phat. 
per m111iliter (Appendix). Since 1.3 milliliters of the sample 
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were used 1n the spectrophotometric reaotion mixture, this gave a 
total ooncentration ot 0.1 micrograms of pyridoxnl phosphate 1n 
the 3 millIliter ouvette. 
Speotral Charaoteristios or P;o:idoll:al PhosP!'l!te 
A speotrtU'!1 was run on a solution containing 1.3 tnll11-
liters of the elution solution 1n 1.7 millilIters of the phos-
phate burrer, but no absorption was shown by thIs concentration 
of pyridoxal phosphate over the range of 225 to 425 millimiorons. 
A speotrum was also run on a solution oontaining 0.3 millIliters 
of reduoed diphosphopy.ridlne nucleotide (O.B milligrams per ml.) 
in phosphate burrer, 1.3 milliliters of the buftered solution ot 
pyridoxal phosphate (O.OB micrograms per- milliliter) and 1.4 mill-
iliters ot 0.1 M. phosphate burter. Aa seen from Table VI (Appen-
dix), the pyridoxal phospha.te, at the conoentration used in this 
experiment, had no effeot on the oxIdation of reduoed CoeM,... I 
slnoe the deereal. In optical denSity atter thirteen hours was 
tha same within experimental error as that shown in Figure I and 
in Table V, in which ca.8 the sample contained only DPNH 1n a 
phosphate butter solution. In higher ?oncentl"'ationa, the pyridoxal 
phosphate shows charaoteristio absorption over the range ot 225 
to 425 millimiorons as seen from r'i&."Ure III and Table VII (Appen-
dix), which represent the absorption of pyridoxal phosphate in a 
concentration of 10 mlcrograme per millilIter. '1'he pyridoxal phos-
phate haa enough 11eht absorption around 400 millimicrons to be 
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yellow (46), but it Rlso has a Charaoteristic speotra in the 
ultraviolet. 
Arter the prote1n traotions were eluted with the bufrer-
ed pyridoxal phosphate solutIon (0.08 miorograms per millIliter), 
the enzymio aotiv1ty of the samples was determined by the speotro-
photo~~trl0 prooedure previously described in Chapter III. A8 seen 
trom. Table III and from It'1Bure IV, the non-enzymat1c transamnat1-
on still offers considerable intex-terence with the enzym.atio trans", 
a.inatlon even at the very low oonoentrations of pyridoxal phos-
phate used here. All of the protein traotions anoved increased 
aotivity Which hal been aSlIu.nted to be due to the non-enzymatic 
transamination. The position of maXimal aotivity is not appreci-
ably altered here, however, but the dirt.reno. In activity between 
the position of mAximal actIvIty and that of the othe~ proteIn 
traotions i8 not a8 d1vergent &8 was observed in Chapter III. In 
this experiment. there appeax-s to be slightly more tx-ansaminase 
activIty in the alphag globul1n traction than 1n the area immed-
iately tollowing this proteIn fraction. The reverse was tound to 
be true In Chapter III In whlch the samples were eluted with phos-
phate buffer. In either ease. however. the largest concentratIon 
of transaminase actIvIty Is associated with the alph&2 globulins 
rather than the beta globulIns as previously proposed. SInce the 
addItIon of pyridoxal phosphate dId not result in greatly In-
creased tr9.nsa.minase acti vi ty In any of the proteIn fItaetlons, 
TABLE III 
'tRA.NSAlSIIASB AOTIVI'l'! OF THE VAftlOUS SERUM PROTEIN 
f'f(ACTIOnS A}i'TI-::R THntTEf:N Harms 
... 
-
1 
Aot&,&b:,Ug&t, 
a I, 4 
1. Albulalna 0.079 0.0&6 0.096 0.136 
7. Beta 0.080 0.083 o.oas 0.074 
8. Beta to Gazrul.ta 0.0'19 0.090 0.101 0.004 
, .. 
0.076 
0.177 
O.OBO 
0.098 
0.051 
50 
~ 
0.18 t-
0.1 ,l-
(/) 
~ 0.12 f-
z 
~ 
>- 0.0 9 f-
> 
f-
(.) 0.06 
<t 
0.03 
-
ALBUMINS ALBUMINS ALPHA-I ALPHA-I ALPHA-2 ALPHA-2 BETA BETA GAMMA 
TO TO TO TO 
ALPHA-I ALPHA-2 BETA GAMMA 
}'IGURE IV 
TRANSAMINASE ACTIVITY OF THE VARIOUS SERUM 
PROTEIN FRACTIONS Al;'TER 'rHIRTEEN HOURS 
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the apoanz:rme in the area o.f the nlpha2 globulins vias appa.rently 
saturated with the coenzyme and, thus, was not separated fl'om the 
coenzyme during the pr008S8 of electrophoresis. These results 
would seem to otter further evidenoe tor the hypothesia ot' a non-
lonio linkage between the apoenzyme and Its ooenzyme. 
CHAPTER V 
F'RAOTIONAL PRECIPITATION OF' SI:':RUM PRO'l"'EINS 
In 1889, Hotm8i.te~ observed that ovalbumin trom the 
wh1t. of the heD'. egg o~etalliz.d in a ooncentrated ammonium 
sultate tiltrate trom which the othe. proteln. of tbe egg white 
had been precipitated (47). Fo~ be.t results the pH ot the 801-
ution tJ"ODl which orystallisation takes plaoe was found to be near 
•• 8 and the t_peratva near 20°C. Ovalbumin prepa~.d by th1. 
method and recryatalllzed •• veral tlm.. has been anown to be pure 
by immunologic and other ortteria (47). 
Albu1a1n may rea411y be orystal11.ed from blood plasma 
of the ~ee by a salting out procedure similar to that described 
tor ovalbumin (47). Moat of the globulins are precipitated at 
halt s.turation (about 2 iii.) of lUDlo:niua sulfate. Incroe •• e in the 
ealt ooncentration precipitate. crystalline albumin •• Thi. mater-
lal, how.ve"., Ie tar trom homogeneous and haa been .eparated into 
.ev •• al dlst1nct traotlons. The pla ... albumin. of most oth.~ 
speole. have p~ov8d difficult to purity or crystall!.e by meana 
or salting out. Human serum albumin has b.en crystalli.ed trom 
ammoniua aultat. by Kendall (31). 1~.ae albumins wh1ch had b.en 
crystalll.ed tour time. were still colored yellow by the pr •• ence 
ot .e:rum plgment •• The o~atallln. human serum albumin 18 a •• oe-
iated with. small amount ot tree fatt7 aold that cannot be re-
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moved without .flrst denaturing the albumin (11). SolubilIty 
meaaure.ent. by KendaU Ind10ated that the crystalline human aer-
a albumin 1. more homogeneous than the COrl"'8spondlngalbum1n 115-
olated from hor.. .erum. 
Cholet ot Prtg&pl\1,iB& ABIO! 
Fftotionatlon by means ot olting out 1. inherently 1 ••• 
powerful than the methods of •• parat10n at low 10nl0 strength, 
either 1n water or in aqueous ethanol. Neurath (47) points out. 
however, that the dellcat. protelna are le •• l1kely to .urter 
4"-6- in the pre.ence ot neutral salt. than in the pre.ence ot 
organio sol.,ents and that the salting out method i. Nat1vely 
more aimpl. and convenient to oarry out wlthout special skill and 
equipment. 
AmMonium saltat. haa been w14ely us.d .a a .alting out 
agent, sinoe it haa a hlgh solubility and roushly neutral reaction 
, 
(pH 5 to 6) In concentrated solut1on (46). In alightly alkal1ne 
solution, ."en at pII 9.3, tlfty per oent of the ammonium lon haa 
already b.en conye~t.4 to ammonia. The pH ot ammonium aulf'ate .01-
ut10ns should be controlled by .eana of a butter. The l1m1ted sol-
ubillty ot sodium sultate tends to restriot Ita use. However, 1t 
1t 1s us.d, oare mult be exercised to carry out une operat1ons 
above saGe. in oPder to avold crystallization ot the decah,-drate. 
Potassium phosphate butters ot known ionic strength and pH are 
etteot!ve but are not soluble enough tor 0.01"7 need. Sodium chlor-
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ide, magne.ium lultate and aodium acetate hay. all been used to • 
l •••• r extent. Th.~. 1. little information about d1rferenoes amon 
the Yarioua aalta with regard to po.aible speoiflc .ttftct. on pro-
te1n precipitation or crystallization. 
~ro22s.~ ~I0h!nl!! ot"Salt~ns Oui" 
The mechllniam ot salting out 1. undoubtedly highly oom-
plex. It baa been Bugge.ted that It was due to dehydration or the 
protein by the added a.lt. Aocordlng to the view developed by 
Debye (le). the salt 10n. attract the polarizable water moleoule. 
around th .... lv •• to a y.r1 large extent, making leas water avail-
able tor the proteina aince, at high aalt concentrations, the num-
ber of charged groupa oontributed bY' the salt 1s large compared 
wIth tho •• by tbe proteins. Since 801ubility ot the protelna 1n 
water 18 thought to depend on the olu8tering ot water molecul •• 
around the hydrophilio 10nlc group., removal ot water molecules to 
other ions w111 decrea •• the protein solubillty_ 
All the proteins studled have been found to be prec1pi-
tated f:rom aClusous .olutior! by hl!~h concentrations of neutral 
salt •• The .Etectlve reglon ot .alting out 1s usually at very high 
ooncentratlons and 1a most etfeot1ve at the 18081eotr10 poInt or 
the proteln. SaltIng out has been round to oocur not only with 
protelns but w1 th gasea, uncharged molecules. and eleotrolytoa. 
~r801nltatlgn Prooedy£! 
In tb1s exper1ment. ammonlum sulfate was used as the 
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precipitating a.~.nt to obtain a pa~tlal traotlonatlon ot tbe •• r-
WI protelns Into the albwRln and slobulJ.n tl'aotlons. The let'WI. 
used was tram human blood sino ... latlve17 large quantttl •• we .. 
nec ••• ary to!' t'Paotlonatlon. The ... p1e. were twent,.-tour boUl' old 
•• tta obtained trOl1 nektoen Inatltute. whlah bad been kept refrig-
erated until ready tor u ••• 
In the preoipltation, 5.0 Jdll1l1te.a ot 41.tI1184 water 
was added to 5.0 ld.lll1ttera of' the serum In a pl.st1c cent .. ltug_ 
tube (50 .tl1111t ... yolume). To tb1. waa added two ~pa or 0.6 N. 
sulfuric acid '.6). Att..,.- Jd.x1n.g the _pl •• , 10 m11UUte •• or a 
aatul"atod solutton of' 4l1mOnl_ aultate ( •• 10 M. at 26°0.) .U add-
ed 8lowly wItb oontlnuou8 .tl~lng and the solutton was allow~ to 
atand tor 20 II1nuha w1 th oce ••• tonal 8t1.1'1ns. The solution was 
them centl"lt'ugGd top SO Jd.nut •• and the _pernat8nt waa 4eoanted 
and .. vad tor the late p"0Ip1'at10n or the albualne. 
Tba pl'eolpltate4 HIlUm globulin •• 8" tben "",di •• olved 
1n the plastl0 oentr1fuge tube witb 8.0 m111111t ... of d1.'111.4 
water. To thi. wa. added 9.0 ~11111t.1'8 ot the aaturated ammon-
lum sulfate solut10n wltb oontlououa at1JlPlng ... bet .... Arte. 
boing allowed to .'and tor ano\hep 10 adDut •• with ocoaa.lonal 
atlrrlng, tn. solutton was agaln o.nt~ltuged ro. 20 minut... The 
supernatant .. 8 decantod and disoarded. The precipitated globul-
ins were d18801vod 1n 9.0 Dd.lllUtera or 0.1 M. phosphate butt ••• 
To the eupernatant ~om the tirat pnolpltatlon of.' the 
globulins, solld ammon1um sulfate (approximately 7 grams) was add-
ed with constant .tl~lng until the solution wns sa.turated wIth 
the •• It. The solutIon waft allowed to stand. tor 30 minutes with 
trequent stiwing. It was then flltered throuyft V .. 1latman No.1 
tilter paper aince it was round that the albumins would not came 
down In the cent~ltug •• The preoipitated albumins W$re then re-
d18s01ved in 4.0 mtlUllteps of 0.1 M. phosphate butter of pH 7.4_ 
The soluttons of •• x-um album1ns an.d elobulins wore tran-
sfe1"l"ed to 410.1:1818 bags made trOJrll A. H. Thomas dialysis tubing 
ilo. 4465-A2. The two solutions we,...., then dialyzed in separate one 
llt.r solutions ot 0.1 M. phosphate burrel' (pH 7.4) for 20 hours 
in the deep tx-&e • ., at ,0C. with oonstant stirring b;r the Magna 
St1r, llUulutactuped by Labol'la.totty Industries, Inc. J Chicago, 111-
inola. Sinoe h •• t 1. generated by the stl~erJ preoautions were 
taken to insure constant temperatul'le or the dinlyslg solutIon by 
placIng aab.sto. mats, •• parated by an air layer, between the 
stIrrer and the solutions and by o1rculating th~ a1r 1n the deep 
tr •••• w1th a _11 tan. 
Atter the d1alysls. tbe solutIons were transferred 
quantItatIvely to 25 m111111ter volum.tric tlssks and diluted to 
voluae wIth 0.1 M. phosphate butter. The trans~m1n~se ~et1vity ot 
the two fractIons was then dete~lned by the 8peetro~hotometrle 
1'1'oeedur., desor1b.d earlier. 
S'Qutr<mbatm:mtr1g Analystl or ;EnIDI Ac~1x1t% 
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In this analys18, 0.5 millillters of the 0.2 M. 1-
aspartate was added to a 3 millI11ter cuvette and to this was 
added 0.1 milllUter of the malic dehydrogenase, 0.3 mtl11l1tell 
of the reduced dlphosphopyrldine nucleotide solution. a 1.5 milli-
lIter aliquot of the tractionated serum protein sample and 0.4 
milliliter of 0.1 M. phosphate burrell. The rererence cell contain-
8d all of the foregolng constltuents except the reduced Coenzyme 
I, which was Ilepla.ed by 0.3 milllliter of 0.1 14. phoaJ)hate butter. 
Atter • 30 minute incubation period at room temperatur., 0.2 mll1-
iltter ot the 0.1 M. alpha-ketoglutarate was added to the reaction 
mixture •• (Dilloetian. tor reagents in appendlx). The reduction 1n 
optical density was then followed for 90 minute. in the Beckman 
DU Spectrophotometer to determine the activity ot the two tract-
ions. The relatty. actlvltl •• of the two protein tractions are 
shown in Table IV and In Figulle V. In thIs ea.e the largeat part 
ot the transamina •• aotivity 18 concentrated In the albumin tract-
10n wIth a small amount of activIty in the globulins. The d1fter-
ence between the activity 1n the globulln and the albumin tract-
10n. is statistically signiticant as indicated by the large t-
value obtained. The t-valu.e 1. calculated on the basia or the 
standard error of the ditterenoe of two meana. 
That the tNUlaaminaa. i8 not .8'P8rated trom 1 ta coenzyme 
during the tractional J)x-ecip1tatlon 1s indicated by the relatively 
large amount ot enzymatic actIvity in the albumin fraotion. 
TABLE IV 
REDUCTION IN OP'I'ICAL DRtiSITY CAUSED BY THE ALBUMIN AND CLOBtJLI1'4 FRAC1'IONS 
OF 0.3 MILLILI~ER HUMAN SERUM SAMPLES OVER A 90 MINUTE PERIOD AT ROOM 
TEMPERATURE 
GLObULINS ALBU1UUS 
Sample Pacreaae Mean Standard Decrease Mean Standard Standard t 
1n OD Deviation 1n OD Deviation Error Value 
0.054 0.226 
No. 1 0.059 + 0.007 0.251 + 0.035 0.0255 7.7 
0.064 - 0.2'16 -
0.062 
0.065 
0.063 ± 0.002 
0.275 
0.269 + 0.008 0.0062 
-
33.2 No. 2 
0.073 0.344 
0.077 
0.075 ± 0.003 
0.386 
0.365 + 0.030 0.0211 
-
No. 3 
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REDUCTIO!: XU OPTICAL DENSITY CAUS:&'1) BY THE ALBUlO:!1 AND 
GLOBULIN F'RACTIONS OF I!UMAN SERUM OVER Po 90 'MINUTE 
PIlUOD 
CHAPTER VI 
SUlGiARY AND CONCLUSIONS 
The enaymatio activity of glutamic oxalacotl0 trans-
aminas. baa been found In serum both 1n the normal and patholOg-
10al atat ••• Th. corullstently elevated lev.ls of th18 enz". 1n 
.erum dur1ng pathologies involvIng necros1s of transaminase rich 
tissues. partIcularly cardIac muscle and liver tissue, has re. 
sult.« In widespread investigation of the c11n1cal implications 
ot this anomaly. The objective of this relearch. however, bas 
been to pre.ent a further bioohemical charaoterization or the 
enz,.. tram the point of view of It. eleotrophoretio mdgratlon 
pattern, ita tractIonal preoipitation properties and the natu" 
ot the linkage betw •• n the .nz~ and ita coenzyme, pyr1doxal 
phosphate. 
By a combination ot the horizontal paper strip method 
ot tonography de8cribed by MoDonald at al (39) and the speotro-
photometric prooedure tor tne determination of glutamic oxalacetio 
transaminase actIvity by Karman (28). the enz,me was found to b. 
asaociated with the alPbaa globulins or the .erum. The maximal 
aotivity waa located 1n the are. immediately tollowlng the alPbaa 
globulins with slightly le88 act1vity in the alphf12 traction it-
.elt. 
The question then arose as to Whether the actIvIty 1n 
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thi. afle" wa. due to the enzyme itselt or whether perhaps the 
aoo.i' had been .eparated from the coenzyme dUl"ing the proce •• ot 
electrophoresi., which m1~~t well be the ca •• if the linkage 
betw •• n the enzyme And the coenzJ!!le is of an ionic rather than a 
non-ionio nature. It this were true, the aotlvlty seen 1n the •• 
ape.s may ".11 have been due to non-enzymatic transamination by 
the pyroidoxal phosphate which may have migrated to this post tion 
and tbe enzyme may have been 1n another traction but inactivated 
by the loas of the coenzyme. Pyridoxal phosphate was then added 
to the speotrophotometric reaction mixture. to determine It any 
or the other traction. would show .ignlfioantly increased activ. 
1ty by aotivation ot the apoen.,.. with the coena,.e. The area ot 
maximal actlvity was not ohanged, however, by the additlon of the 
coenzyme. In this cae. the alphag globulIns contained the maximal 
actlvIt7 w1th slIghtly lee. activIty In the are. immediately trail 
ing this serum prote1n fraotion. Since the additlon or pyrIdoxal 
phosphate dId not result 1n gr •• tly Increa.ed act1vity In any or 
the other fractions, the apoenzyme 1n the vicinity of the alphaS 
globullns was apparently supplied wlth the coenzyme and, thus, was 
not separated from the coenzyme durlrtg the process of electropho-
resis. These results would .eem to otfer i'U%'tht'tr evidence tor the 
hypothes1s of a non-1onic IInkllgo between the apoenzym.e and its 
coenzyme. 
In the fractional precipitation of the serum proteina to 
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determine with which fract10n the trsnsaminaa6 was a.sociated, 
the proteins were removed from solution by the process known as 
U" 1 salting out • using ammonium sulfnte as the preolp tatlnp, agent. 
Significantly more activity was found in the albQ~1n fraction 
than In the globulins as denoted by the large t-value obt~lned. 
Th. transaminase ap~arently is not separated trom the pyridoxal 
phosphate during the preoipitation prooedure sinoe there is a 
relatively larhe a~ount of transaminase activity in the albumin 
traction. 
APPEliDI).. 
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REAGENTS 
1. Alpha-ketoglutarate, 0.1 M. 
DI •• olved 1.47 grams alpha-ketoglutaric acid (Sigma 
Chem. 00., St. Louis, Hissouri. K56-63) in 70 milllliters 
phosphate but"f'er solution (No.5). Adjusted to pH 7.4 wlth 
1 N. HaOM (approxlmately 20 milliliters) and diluted to 100 
ml11ilitor. wlth phosphate butter. Kept tro •• n. 
2. l-Aapartate, 0.2 M. 
Dlsso1ved 2.662 grams l-a.p~!c aold (Worthlngton 
Blochemioal Corp., F~:r.ehold, lle. Jerse,., Mathe.on 5950-
390067) in 70 m1111Uter8 phosphat. butter solution (No.5). 
A.dJusted to pH 7.4 with 1 N. BaOH (appro.x1mately 20 milll-
litera). Diluted to 100 ml11l11ter8 wlth phosphate butter. 
Kept fro.en. 
3. Bros Phenol Blue Stain. 
Di.solved 2.0 gram. Brom Phenol Blue In 190 milliliter. 
ot 95 per oent ethanol saturated with mercuric ohloride. Add-
e4 1.0 milliliter ot glaoial acetic ao14, mixed and flltered. 
4. Malle Dehydrogenase (50 micrograms per mill!l! tor) • 
Dlluted 0.20 milll1iter ot malic dehydrogenase (2.5 
milligrams per millilIter, Vforth1ngton Bioohemical Corp., 
Freehold, New Jersey, MA5514) to 10.0 milliliters wlth phos-
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phate butfer solution (No.5). Kept refrigerated at SoC. 
5. Phosphate Bufter, 0.1 M., pH 7.4. 
Di.solved 13.97 grams anhydroua K2HP04 and 2.69 gram. 
anhydrous KH2P04 in distIlled water and diluted to 1 liter. 
Kept refrigerated at soc. 
S. Pyridoxal Phosphatee 
Sol. Xl Dissolved 4. milligrama pyridoxal-5-phosPhateeU20 
(Californ1& .r'oundat1on for Biochemioal Reaearch, Loa Angel.a, 
California, Lot 1.50892) in 10.0 millIliters phosphate butter 
(No.5) e 
Sol. II: Diluted 0.2 milliliter Sol. I to 100 milli-
liters with phosphate burrer (No.5). This gives a concen-
tration of 0.8 micrograms pyridoxal phosphate per milliliter. 
Sol. III: Diluted 10 milliliters Sol. II to 100 milli-
lIters with phosphate butfer 0;0. 5). This gives a conoen-
tration of 0.08 miorograms pyridoxal phosphate per milliliter. 
Kept all pyr1doxal phosphate solutiona refrIgerated at SoC. 
7. Reduoed Diphosphopyridine Nucleotide, o.a milligram per milli-
liter. 
Dissolved 4 mll11erams ot reduced dlplloapbopyrid1ne 
nucleotide (Slgma Chem. Co., St. Louis, Missouri, Lot 108-110) 
In 5 milllliters phosphate burrel' solution (Uo. 5). Kept re-
o trig.rated at 5 C. 
8. Veronal Burrer, 0.0'172 M." pH 8.9, ionlc strength ot: 0.0'1. 
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Dissolved 2.80 grams dlethylbarblturlc aoid and 28.68 
grams sodium dlethylbarblturate 1n distilled water and diluted 
to 2 liters. 
THE AbSORP~rIOH SPECTRA OP' REDUCED DIPHOSPHOPYRIDINE 
NUCLEOTIDE (approximately 0.08 mg./ml.) Hf 0.1 MOLAR 
PHOE;PHA'1'E BUJ.'F'ER 
OPTICAL DENSITY 
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Wave Length 
(mu) At Tim.e After 13 
Zero Soups 
450 0.001 0.004-
445 0.002 0.00.& 
'"0 0.002 0.004: 
435 O.ooa O.()(M 
430 0.008 0.004 
425 0.002 0.004 
420 0.001 0.003 
415 0.002 0.004 
410 0.004 0.004 
405 0.006 0.004 
400 o.au 0.011 
395 0.022 0.020 
390 0.038 0.036 
385 0.065 0.059 
S80 0.108 0.094 
375 0.162 0.137 
Wave Length 
(mu) 
370 
365 
360 
355 
350 
345 
340 
335 
330 
325 
320 
315 
310 
305 
300 
295 
a90 
285 
280 
275 
TABLE V (continued) 
OPTICAL DENSITY 
At T ill'le Atter 13 
z.~o Hour. 
0.22S 0.190 
0.287 0.245 
0.355 O.SOO 
0.419 0.354 
0.462 0.395 
0.495 0.422 
0.511 0.430 
0.500 0.425 
0.475 0.401 
0.435 0.367 
0.380 0.325 
0.325 0.281 
0.269 0.243 
0.219 0.224 
0.181 0.228 
0.154 0.251 
0.148 0.304 
0.196 0.390 
0.364 0.580 
0.649 0.865 
Wave Length 
(mu) 
270 
265 
260 
255 
250 
245 
240 
236 
230 
225 
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TA3LE V (continued) 
OPTICAL DE1{SITY 
At Time After 13 
4ero Hours 
1.020 1.241 
1.305 1.492 
1.412 1.561 
1.325 1.453 
1.120 1.198 
0 .. 880 0.920 
0.700 0.720 
0.620 0.619 
0.640 0.621 
0.7'12 0.740 
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TABLE VI 
THE ABSORPTION SPEC'l'RA Of' REDUCED DIPHOSPHOPYRIDINE 
NIJCLhOl*IDE (approximately 0.08 mg./ml.) IN 0.1 MOLAR 
PHOSPHATE BUf'F'ER CON'rAINnm 0.04 l!ICROGHAMS PYl{IDOXAL 
Wave Length 
(mu) 
450 
445 
440 
430 
420 
410 
400 
395 
390 
385 
380 
175 
1'10 
365 
360 
FIfOS-FHA'I'E: PER MILLILITER 
OPTICAL DEllSITY 
At Time Atter 13 
Zero Hours 
0.000 0.005 
0.001 0.006 
0.001 0.006 
0.000 0.006 
0.003 0.007 
0.003 0.007 
O.OU 0.014 
0.082 0.024 
0.038 0.039 
0.065 0.061 
0.106 0.097 
0.156 0.138 
0.219 0.190 
0.283 0.245 
0.350 0.299 
Way. Length 
(mu) 
355 
350 
345 
340 
336 
330 
325 
320 
315 
310 
305 
300 
295 
290 
285 
280 
2"15 
270 
265 
260 
TABLE VI (oontinued) 
OPTICAL DENSITY 
71 
A t Time After 13 
Zero Hours 
0.417 0.350 
0.461 0.35010 
0.492 0.418 
0.513 0.425 
0.496 0.421 
0.470 0.397 
0.431 0.364 
0.376 0.323 
0.320 0.280 
0.265 0.243 
0.215 0.224 
0.1'18 0.230 
0.152 0.260 
0.146 0.308 
0.193 0.395 
0.359 0.582 
0.542 0.865 
1.015 1.231 
1.300 1.487 
1.408 1.558 
Wave Leneth 
(mu) 
255 
250 
245 
240 
235 
230 
225 
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TABLE VI (continued) 
OPTIOAL DENSITY 
At Time After 13 
Zero Hour. 
1.320 1.424 
1.117 1.193 
0.875 0.920 
0.695 0.721 
0.515 0.622 
0.637 0.629 
0.769 0.742 
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TABLE VII 
'l'HE ABSORPTION SPECTRUM Or' PYRIDOXAL PH03PHA'1'E (10 micro-
grams per milliliter) IN 0.1 M. PHOSPHATE BUFf'ER SOLUTION 
Wave Length (mu) 
450 
445 
440 
.35 
410 
42e 
410 
415 
410 
405 
400 
395 
390 
385 
380 
375 
370 
365 
Optical 
Den.tty 
0.015 
0.025 
0.041 
0.066 
0.099 
0.144 
0.196 
0.256 
0.307 
0.356 
0.396 
0.422 
0.434 
0.432 
0.420 
0.396 
0.365 
0.330 
Wave Length 
(mu) 
360 
355 
350 
348 
345 
343 
340 
338 
335 
333 
330 
328 
325 
323 
320 
318 
315 
313 
Optical 
nen.tty 
0.293 
'0.259 
0.228 
0.119 
0.207 
0.203 
0.200 
0.200 
0.203 
0.205 
0.208 
0.a08 
0.206 
0.202 
0.192 
0.184 
0.169 
0.158 
Wave Length (mu) 
310 .. 
308 
aotS 
303 
300 
295 
290 
285 
280 
275 
Optical 
Density 
0.142 
0.130 
0.115 
0.108 
0.095 
0.079 
0.076 
0.080 
0.090 
0.10~ 
TABLE VII (oontinued) 
Wave Length (mu) 
270 
B65 
260 
255 
250 
245 
240 
235 
230 
225 
7. 
Optical 
Density 
0.120 
0.141 
0.196 
0.254 
0.310 
0.400 
0.634 
0.865 
0.9'10 
1.029 
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